Ge Healthcare Techs (GEHC) closed at $80.64 on November 20, 2026, down 1.5% from the previous close, on volume of 3,447,478 shares (30-day average 3,775,142).
Data as of November 20, 2026.
20-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 18, 2026 | Diagonal Call Spread | 20-Nov : 18-Dec-2683 : 85 C | 3,002 |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | |||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 20, 2026. See the largest for 5, 30, 60 and 90 days
Business Wire (Fri, 20-Nov 9:00 AM ET)
Business Wire (Thu, 19-Nov 8:00 AM ET)
GE HealthCare brings advanced visualization into InteleViewer to support radiology workflows
Business Wire (Wed, 18-Nov 9:00 AM ET)
Business Wire (Tue, 17-Nov 8:00 AM ET)
Business Wire (Mon, 16-Nov 8:00 AM ET)
Business Wire (Tue, 10-Nov 8:00 AM ET)
Business Wire (Tue, 3-Nov 9:00 AM ET)
Business Wire (Sun, 1-Nov 12:35 PM ET)
GE HealthCare raises 2026 outlook after 6.2% organic revenue growth and a 16.6% adjusted EBIT margin
Market Chameleon (Wed, 28-Oct 3:10 AM ET)
GE HealthCare reports third quarter 2026 financial results
Business Wire (Wed, 28-Oct 6:20 AM ET)
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ge Healthcare Techs trades on the NASDAQ stock market under the symbol GEHC.
As of November 20, 2026, GEHC stock price declined to $80.64 with 3,447,478 million shares trading.
GEHC has a beta of 0.41, meaning it tends to be less sensitive to market movements. GEHC has a correlation of 0.03 to the broad based SPY ETF.
GEHC has a market cap of $36.42 billion. This is considered a Large Cap stock.
Last quarter Ge Healthcare Techs reported $6 billion in Revenue and $1.34 earnings per share. This beat revenue expectation by $159 million and exceeded earnings estimates by $.13.
In the last 3 years, GEHC traded as high as $94.80 and as low as $57.65.
The top ETF exchange traded funds that GEHC belongs to (by Net Assets): VOO, VTI, QQQ, VO, IVV.
GEHC has outperformed the market in the last year with a price return of +8.1% while the SPY ETF gained +6.9%. GEHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +8.9% and -2.1%, respectively, while the SPY returned -9.3% and -6.2%, respectively.
GEHC support price is $80.10 and resistance is $83.68 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GEHC shares will trade within this expected range on the day.